Participating in the exhibition for the first time
Release time:
2023-04-12
This exhibition has more than 500 exhibitors and many distributors from all over the country. Everyone gathered together and the grand occasion was unprecedented. Before the exhibition hall opened, many participants had already lined up at the door. The exhibition site was crowded with people and bustling. Health food, nutritional food, special medical food, medical equipment, group purchase supermarket, community live broadcast, tourism products, tonic products, health appliances, Chinese medicine therapy, etc., products, products, categories.
Walking in the crowded exhibition hall, the biggest feeling is that there are a lot of health food and experience equipment. What has increased this year is the categories of new formats and new fields, such as factory tours and residential tours. Group buying supermarkets can be seen everywhere, and green agricultural products and agricultural assistance projects can be found everywhere. The number of pension projects of various levels is also far higher than that of previous years; publicity such as "strong support from local governments (some also have live videos from county heads)", "promotion of satellite programs on CCTV and satellite TV", "cooperation projects between a certain provincial (city) health committee and a certain control center" and "365-day live broadcasts" can be found everywhere. Times have changed, needs have changed, markets have changed.
The exhibition is also on the third floor of the exhibition. The 2023 China (Nanjing) Community Health Development Conference was specially held. More than 400 industry colleagues gathered together to participate in the grand event. The content of the meeting was colorful, with the truth, the truth and dry goods constantly, which made the audience feel more enjoyable and more confident. There are 0.25 billion old people in China. This is our confidence and our market foundation.
We have 7 colleagues participating in this exhibition. We have united and cooperated, assisted each other, and added the contact information of more than 80 customers. Among them, there are 7 groups of customers who have in-depth discussions, and all have follow-up follow-up. This is my first time to participate in the exhibition, and as an exhibitor, as a new post for me, this is a rare opportunity. Although I feel that my legs are not my own these days, I have learned a lot. Take the reception of customers as an example. Laughing is very knowledgeable about customers, courteous reception, introduction of products, exchange of business cards, etc. There are so many similar products on the market, how should we ask customers to buy our products? Before the exhibition, the marketing department prepared the sharing of product information, and we discussed together. The exhibition site even shared experience without reservation, which made me more confident. From the beginning, I was embarrassed to send publicity materials, to the first time I added contact information with strange customers, which benefited from the encouragement and help of my colleagues. This exhibition has benefited me a lot, and also made me understand that there are more industry knowledge and industry terms waiting for me to learn. (Pang Jingyu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page